The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

Explore bluebird bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BLUE. Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $ ...

Explore Bio-Rad Laboratories stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BIO. Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5% ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

Pow.Bio Fermenters Pow.Bio Fermenters ALAMEDA, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Pow.Bio, a leader in innovative ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...

Highlights,Citigroup revised its price target for Bio-Techne, reflecting varied market sentiment.,The company’s stock has ...

Highlights,Belite Bio progresses Phase 3 DRAGON trial with positive interim analysis of Tinlarebant.,Data Safety Monitoring Board recommends trial continuation, with no changes to the sample ...

Researchers have now developed a novel bio-hybrid drone by combining robotic elements with odor-sensing antennae from silkworm moths. Their innovation, which integrates the agility and precision ...

March 11 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab will acquire 2seventy bio (TSVT.O), opens new tab for about $286 million in cash, sending the cancer cell therapy maker's shares up ...